^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    RLY-2139

    i
    Other names: RLY-2139
    Associations
    News
    Trials
    Company:
    Relay Therap
    Drug class:
    CDK2 inhibitor
    Related drugs:
    Associations
    News
    Trials